Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 4
2005 5
2006 5
2007 11
2008 14
2009 21
2010 4
2011 4
2012 5
2013 10
2014 10
2015 15
2016 13
2017 21
2018 12
2019 15
2020 16
2021 17
2022 9
2023 7
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

189 results

Results by year

Filters applied: . Clear all
Page 1
Correction: Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NET.
Singh S, Ferone D, Capdevila J, Chan JA, de Herder WW, Halperin D, Mailman J, Hellström L, Liedman H, Svedberg A, Tiberg F. Singh S, et al. Among authors: ferone d. Trials. 2024 May 2;25(1):297. doi: 10.1186/s13063-024-08146-1. Trials. 2024. PMID: 38698434 Free PMC article. No abstract available.
Challenging diagnosis of resistance to thyroid hormone in a patient with COVID-19, pituitary microadenoma and unusual response to octreotide long-acting release test.
Petolicchio C, Brasili S, Gay S, Cocchiara F, Campi I, Persani L, Vera L, Ferone D, Gatto F. Petolicchio C, et al. Among authors: ferone d. Endocrinol Diabetes Metab Case Rep. 2024 Apr 17;2024(2):23-0146. doi: 10.1530/EDM-23-0146. Print 2024 Apr 1. Endocrinol Diabetes Metab Case Rep. 2024. PMID: 38642577 Free PMC article.
Ianus Bifrons: The Two Faces of Metformin.
Goglia U, Hasballa I, Teti C, Boschetti M, Ferone D, Albertelli M. Goglia U, et al. Among authors: ferone d. Cancers (Basel). 2024 Mar 26;16(7):1287. doi: 10.3390/cancers16071287. Cancers (Basel). 2024. PMID: 38610965 Free PMC article. Review.
Skeletal Muscle Evaluation in Patients With Acromegaly.
Milioto A, Corica G, Nista F, Wildemberg LEA, Rossi F, Bignotti B, Gadelha MR, Ferone D, Tagliafico AS, Gatto F. Milioto A, et al. Among authors: ferone d. J Endocr Soc. 2024 Feb 18;8(4):bvae032. doi: 10.1210/jendso/bvae032. eCollection 2024 Feb 19. J Endocr Soc. 2024. PMID: 38434516 Free PMC article. Review.
Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NET.
Singh S, Ferone D, Capdevila J, Chan JA, de Herder WW, Halperin D, Mailman J, Hellström L, Liedman H, Svedberg A, Tiberg F. Singh S, et al. Among authors: ferone d. Trials. 2024 Jan 16;25(1):58. doi: 10.1186/s13063-023-07834-8. Trials. 2024. PMID: 38229199 Free PMC article. Clinical Trial.
Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national database.
Panzuto F, Partelli S, Campana D, de Braud F, Spada F, Cives M, Tafuto S, Bertuzzi A, Gelsomino F, Bergamo F, Marcucci S, Mastrangelo L, Massironi S, Appetecchia M, Filice A, Badalamenti G, Bartolomei M, Amoroso V, Landoni L, Rodriquenz MG, Valente M, Colao A, Isidori A, Fanciulli G, Bollina R, Ciola M, Butturini G, Marconcini R, Arvat E, Cinieri S, Berardi R, Baldari S, Riccardi F, Spoto C, Giuffrida D, Gattuso D, Ferone D, Rinzivillo M, Bertani E, Versari A, Zerbi A, Lamberti G, Lauricella E, Pusceddu S, Fazio N, Dell'Unto E, Marini M, Falconi M. Panzuto F, et al. Among authors: ferone d. Endocrine. 2024 Apr;84(1):42-47. doi: 10.1007/s12020-023-03649-4. Epub 2024 Jan 4. Endocrine. 2024. PMID: 38175391 Free PMC article. Review.
Optimising Radioligand Therapy for Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumours: Expert Opinion from an Italian Multidisciplinary Group.
Fazio N, Falconi M, Foglia E, Bartolomei M, Berruti A, D'Onofrio M, Ferone D, Giordano A, Grimaldi F, Milione M, Panzuto F, Santimaria M, Schillaci O, Seregni E, Stasi M, Volante M, Lastoria S. Fazio N, et al. Among authors: ferone d. Adv Ther. 2024 Jan;41(1):113-129. doi: 10.1007/s12325-023-02714-8. Epub 2023 Nov 21. Adv Ther. 2024. PMID: 37987917 Free PMC article. Review.
189 results